Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2838 of 6351
-
New drug combo aims to boost platelets in bleeding disorder
Disease control Not yet recruitingThe goal of this clinical trial is to find the best dose of zanubrutinib when used together with high-dose dexamethasone for adults who are newly diagnosed with primary immune thrombocytopenia (ITP), and to learn how safe and effective this combination treatment is.
Phase 1 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Weighted blankets may ease anxiety for cancer patients during IV therapy
Symptom relief Recruiting nowProtocol Title: Protocol Title: The Effect of using Weighted Blanket on anxiety, stress, depression and comfort level among Patients with cancer undergoing intravenous (IV) anticancer therapy and its feasibility of use by nurses compared to routine care; a Randomized controlled s…
Sponsor: Sultan Qaboos Comprehensive Cancer Center • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Heartbeat clues: could your pulse predict IBD drug success?
Knowledge-focused By invitation onlyThis is a prospective, multicenter, observational cohort study, which plans to enroll patients with active IBD who are scheduled to initiate IFX or VDZ treatment between October 2025 and October 2027 at Xijing Hospital, Tang-du Hospital, and Air Force 986 Hospital. All patients w…
Sponsor: Xijing Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New scan could reveal hidden cancer spread in breast cancer patients
Diagnosis Recruiting nowThis study aims to evaluate the detection rate of distant metastases using \[18F\]FES PET/CT in patients with low-grade, ER-positive stage III breast cancer.
Phase 2 • Sponsor: Asan Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Which diabetes drug wins? new study pits dapagliflozin vs empagliflozin
Disease control Not yet recruitingThis study aims to compare the effect of two drugs used to treat diabetes, that is, Dapagliflozin and Empagliflozin on HbA1c (which is an indicator of blood sugar over the last 3 months) body weight, liver and kidney function, blood pressure, and overall cost-effectiveness in pat…
Phase 4 • Sponsor: Bhavya Bhavya, MD • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Fatigue fighter: supplement trial for liver cancer patients
Symptom relief Recruiting nowThis study is a prospective, randomized controlled study on nutritional support and metabolic regulation. It assesses the safety, compliance, and improvement of metabolic/physical-related indicators when using β-alanine within the specified dose range as dietary supplementation, …
Phase 2 • Sponsor: Peking Union Medical College Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
Kids with chronic conditions walk stronger with VR at home
Symptom relief Recruiting nowOver the past 30 years, the prevalence of congenital or acquired chronic diseases in children has risen, affecting between 10 and 30% of them, or at least 100,000 children in France. Pathologies such as cerebral palsy (CP), neuromuscular diseases (NMD), obesity or congenital hear…
Sponsor: University Hospital, Angers • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Ear-Zap device may cut opioid use after spinal surgery
Symptom relief Not yet recruitingTranscutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive, novel neuromodulation technique. Previous studies have demonstrated its safety and efficacy in chronic pain, mental disorders, and other diseases, but evidence regarding its use in acute postoperative pai…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Robot takes the strain out of gallstone surgery
Disease control OngoingConventional endoscopic retrograde cholangiopancreatography (ERCP) is performed under fluoroscopic guidance, exposing endoscopists to ionizing radiation and posing risks of work-related musculoskeletal injury. Robotic-assisted ERCP may mitigate these occupational hazards and pote…
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New heartburn test could replace uncomfortable procedures
Diagnosis By invitation onlyAmong patients suffering from gastroesophageal reflux disease (GERD) symptoms, esophageal pH monitoring and the assessment of symptom-reflux correlation can identify two distinct subgroups characterized by normal acid exposure: functional heartburn and reflux hypersensitivity. Gi…
Sponsor: Fu Jen Catholic University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:08 UTC
-
New eye drops aim to halt keratoconus progression
Disease control Recruiting nowMulti-center, parallel-group, placebo-controlled trial designed to assess the safety and efficacy of twice-daily topically administered GLK-221 Ophthalmic Solution in subjects with keratoconus.
Phase 2 • Sponsor: Glaukos Corporation • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could stem cell vesicles treat spinal cord cavities?
Disease control OngoingThis is a open-label, single-arm, dose escalation phase I clinical trial. The goal of this clinical trial is to evaluate the safety and preliminary efficacy of Intrathecal injection human umbilical cord-derived mesenchymal stromal cell-derived extracellular vesicle (hUC-MSC-sEV) …
Phase 1 • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Peer coaches may boost opioid treatment success
Disease control Recruiting nowThe goal of this clinical trial is to learn if receiving peer recovery support (support services provided by trained "peers" with lived experience of addiction and recovery) improves retention in medication treatment among people with opioid use disorder. The main question it aim…
Sponsor: Geisinger Clinic • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Can we fix iron in food for starving kids?
Knowledge-focused Recruiting nowReports from the Kenya Red Cross Society (KRCS) in Kwale County, southern Kenya, indicate a limited impact of Ready-to-Use Therapeutic Foods (RUTFs) on malnutrition or anemia. The current RUTF formulation may have an excessively high iron content. In severely acutely malnourished…
Sponsor: ETH Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Blood cytokines may hold key to predicting vitiligo progression
Knowledge-focused Not yet recruitingVitiligo is a chronic autoimmune disorder characterized by depigmented patches on the skin, which can pose significant psychosocial challenges, particularly for individuals with darker skin tones. Compared to the general population, individuals with vitiligo are more likely to ex…
Sponsor: Xijing Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
New shot for solid tumors enters early human testing
Disease control Recruiting nowThe study is being conducted to evaluate the pharmacokinetics , safety, tolerability and efficacy in patients with solid tumor.
Phase 1 • Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New pill aimed at Hard-to-Treat GVHD enters early human testing
Disease control Recruiting nowOpen-label, dose escalation study to evaluate safety, tolerability pharmacokinetic and pharmacodynamic activity, and efficacy of Adrixetinib (Q702) in subjects with relapsed or refractory active chronic graft-versus-host disease (cGVHD).
Phase 1 • Sponsor: Qurient Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New combo therapy for lung scarring and high blood pressure under study
Disease control Recruiting nowThis is a Phase 2, open-label, multi-center clinical study to evaluate the safety and tolerability of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung disease (PH-ILD) on a background inhaled treprostinil.
Phase 2 • Sponsor: Pulmovant, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New hope for DM1: Long-Term safety trial of PGN-EDODM1 now recruiting
Disease control Recruiting nowThe purpose of this study is to learn about the long-term safety and tolerability of PGN-EDODM1 in participants with myotonic dystrophy type 1 (DM1) who have completed a prior study with PGN-EDODM1.
Phase 2 • Sponsor: PepGen Inc • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New handheld scanner could help surgeons see skin cancer edges without cutting
Diagnosis Recruiting nowTo assess the feasibility and provide information on the utility of noninvasive line field confocal optical coherence tomography (LC-OCT) for the presurgical assessment of Mohs micrographic surgery sites in patients undergoing removal of cutaneous basal cell carcinomas (BCC).
Sponsor: Roswell Park Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 13:02 UTC